EGLU
From Wikipedia, the free encyclopedia
 |
|
| Identifiers | |
|---|---|
|
|
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C7H13NO4 |
| Molar mass | 175.182 g/mol |
| 3D model (JSmol) | |
|
|
|
|
  (what is this?) (verify) |
|
(2S)-α-Ethylglutamic acid (EGLU) is a drug that is used in neuroscience research. It was one of the first compounds found that acts as a selective antagonist for the group II metabotropic glutamate receptors (mGluR2/3), and so has been useful in the characterisation and study of this receptor subfamily.[1][2][3][4][5][6][7]
References[edit]
- ^ Jane, DE; Thomas, NK; Tse, HW; Watkins, JC (1996). "Potent antagonists at the L-AP4- and (1S,3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord". Neuropharmacology. 35 (8): 1029–35. PMID 9121605. doi:10.1016/S0028-3908(96)00048-2.
- ^ Huang, L; Rowan, MJ; Anwyl, R (1999). "Induction of long-lasting depression by (+)-alpha-methyl-4-carboxyphenylglycine and other group II mGlu receptor ligands in the dentate gyrus of the hippocampus in vitro". European Journal of Pharmacology. 366 (2–3): 151–8. PMID 10082195. doi:10.1016/S0014-2999(98)00918-2.
- ^ Palazzo, E; Marabese, I; De Novellis, V; Oliva, P; Rossi, F; Berrino, L; Rossi, F; Maione, S (2001). "Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception". Neuropharmacology. 40 (3): 319–26. PMID 11166324. doi:10.1016/S0028-3908(00)00160-X.
- ^ Iserhot, C; Gebhardt, C; Schmitz, D; Heinemann, U (2004). "Glutamate transporters and metabotropic receptors regulate excitatory neurotransmission in the medial entorhinal cortex of the rat". Brain Research. 1027 (1–2): 151–60. PMID 15494166. doi:10.1016/j.brainres.2004.08.052.
- ^ Cahusac, PM; Wan, H (2007). "Group II metabotropic glutamate receptors reduce excitatory but not inhibitory neurotransmission in rat barrel cortex in vivo". Neuroscience. 146 (1): 202–12. PMID 17346894. doi:10.1016/j.neuroscience.2007.01.049.
- ^ Kim, WY; Vezina, P; Kim, JH (2008). "Blockade of group II, but not group I, mGluRs in the rat nucleus accumbens inhibits the expression of conditioned hyperactivity in an amphetamine-associated environment". Behavioural Brain Research. 191 (1): 62–6. PMID 18433894. doi:10.1016/j.bbr.2008.03.010.
- ^ Altinbilek, B; Manahan-Vaughan, D (2009). "A specific role for group II metabotropic glutamate receptors in hippocampal long-term depression and spatial memory". Neuroscience. 158 (1): 149–58. PMID 18722513. doi:10.1016/j.neuroscience.2008.07.045.
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
